Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Para-substituted phenylalanine-4 analogues of [L-Ala3]DPDPE: highly selective delta opioid receptor ligands.

Haaseth RC, Zalewska T, Davis P, Yamamura HI, Porreca F, Hruby VJ.

J Pept Res. 1997 Sep;50(3):171-7.

PMID:
9309580
2.

Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptides.

Ramaswami V, Zhu X, Romanowski M, Haaseth RC, Misicka A, Lipkowski AW, Hruby VJ, O'Brien DF.

Int J Pept Protein Res. 1996 Jul;48(1):87-94.

PMID:
8844267
3.

Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.

Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F.

J Pharmacol Exp Ther. 1995 Dec;275(3):1535-42.

PMID:
8531126
4.

[L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.

Haaseth RC, Horan PJ, Bilsky EJ, Davis P, Zalewska T, Slaninova J, Yamamura HI, Weber SJ, Davis TP, Porreca F, et al.

J Med Chem. 1994 May 27;37(11):1572-7.

PMID:
8201592
5.

Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.

Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.

Eur J Pharmacol. 1994 Feb 3;252(2):133-7.

6.

Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.

Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI.

J Pharmacol Exp Ther. 1994 Feb;268(2):836-46.

PMID:
8113996
7.

Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.

Weber SJ, Abbruscato TJ, Brownson EA, Lipkowski AW, Polt R, Misicka A, Haaseth RC, Bartosz H, Hruby VJ, Davis TP.

J Pharmacol Exp Ther. 1993 Sep;266(3):1649-55.

PMID:
8371162
8.
9.

Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.

Wild KD, Horan PJ, Misicka A, Lipkowski A, Haaseth RC, Matsunaga TO, Hruby VJ, Toth G, Borsodi A, Yamamura HI, et al.

Eur J Pharmacol. 1993 Jun 15;246(1):25-31.

PMID:
8394818
10.

Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.

Horan PJ, Wild KD, Misicka A, Lipkowski A, Haaseth RC, Hruby VJ, Weber SJ, Davis TP, Yamamura HI, Porreca F.

J Pharmacol Exp Ther. 1993 May;265(2):896-902.

PMID:
8388462
11.

Opioid peptide interactions with lipid bilayer membranes.

Ramaswami V, Haaseth RC, Matsunaga TO, Hruby VJ, O'Brien DF.

Biochim Biophys Acta. 1992 Aug 24;1109(2):195-202. Erratum in: Biochim Biophys Acta 1992 Oct 19;1111(1):143.

PMID:
1520696
12.

Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin.

Hansen DW Jr, Stapelfeld A, Savage MA, Reichman M, Hammond DL, Haaseth RC, Mosberg HI.

J Med Chem. 1992 Feb 21;35(4):684-7.

PMID:
1311764
13.

Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity.

Horan P, Tallarida RJ, Haaseth RC, Matsunaga TO, Hruby VJ, Porreca F.

Life Sci. 1992;50(20):1535-41.

PMID:
1315897
14.

Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.

Kramer TH, Toth G, Haaseth RC, Matsunaga TO, Davis P, Hruby VJ, Burks TF.

Life Sci. 1991;48(9):881-6.

PMID:
1847736
15.

Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.

Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB.

Mol Pharmacol. 1990 Dec;38(6):924-8.

PMID:
2174509
16.
17.
18.

Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.

Mosberg HI, Haaseth RC, Ramalingam K, Mansour A, Akil H, Woodard RW.

Int J Pept Protein Res. 1988 Jul;32(1):1-8.

Supplemental Content

Loading ...
Support Center